BSECompany Update3 Aug 2026 · 3 Aug 2026, 08:44 pm
As per attachment
GlaxoSmithKline Pharmaceuticals Ltd · 500660
✦ AI SummaryMgmt Change
GlaxoSmithKline Pharmaceuticals Ltd has announced the outcome of its analyst/institutional investor meetings, with the recording available on its website.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Attachments (1)
📄pdf
Download →
5e877b3a-6159-497c-9c71-0218719bc95c.pdf
View document text
GlaxoSmithKline Pharmaceuticals Limited
GSK House, Dr. Annie Besant Road,
Worli, Mumbai - 400 030
Tel No: +91 22 2495 9595
Fax No: +91 22 2495 9494
Web: www.gsk-india.com
Email: askus@gsk.com
3rd August 2026
BSE LIMITED THE NATIONAL STOCK EXCHANGE OF INDIA LIMITED
Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot No. C/1, G Block
Dalal Street Bandra-Kurla Complex, Bandra (East)
Mumbai - 400001 Mumbai - 400051
Dear Sirs,
Subject: Outcome of Schedule of Analyst / Institutional Investor Meetings
Pursuant to Regulation 30 read with Part A of Schedule Ill of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, the recording is uploaded at Audio file –
https://india-pharma.gsk.com/en-in/investors/analyst-meets/
Thanking you,
Yours faithfully
For GlaxoSmithKline Pharmaceuticals Limited
Ajay Nadkarni
Vice President – Administration, Real Estate
& Company Secretary
CIN: L24239MH1924PLC001151